Difference between revisions of "Vendor:PDS Group Holding AG"
From LIMSWiki
Jump to navigationJump to searchm (Move page script moved page PDS Group Holding AG to Vendor:PDS Group Holding AG without leaving a redirect) |
Shawndouglas (talk | contribs) m (Text replacement - "Instem LSS Limited" to "Instem LSS Limited") |
||
| Line 48: | Line 48: | ||
On March 21, 2014, PDS announced it would be rebranding its PathData, ReproData, and ToxData products<ref name="ArchPDSProds">{{cite web |url=http://pds-europe.com/products |archiveurl=https://web.archive.org/web/20131119160957/http://pds-europe.com/products |title=Products - The PDS Product Suite |publisher=Pathology Data Systems Ltd |archivedate=19 November 2013 |accessdate=10 September 2014}}</ref> as an integrated modular software suite called Ascentos.<ref name="PDSRebrand">{{cite web |url=http://www.pdslifesciences.com/march212014.aspx |title=PDS Set to Launch New Products and Branding at Society of Toxicology Annual Meeting |publisher=Pathology Data Systems Ltd |accessdate=10 September 2014}}</ref><ref name="ArchPDSHome">{{cite web |url=http://www.pdslifesciences.com/default.aspx |archiveurl=https://web.archive.org/web/20140910190827/http://www.pdslifesciences.com/default.aspx |title=PDS - Home |publisher=Pathology Data Systems Ltd |archivedate=10 September 2014 |accessdate=10 September 2014}}</ref> However, it's not clear if the modules function as stand-alone software like their predecessors or as dependent modules of the Ascentos platform. | On March 21, 2014, PDS announced it would be rebranding its PathData, ReproData, and ToxData products<ref name="ArchPDSProds">{{cite web |url=http://pds-europe.com/products |archiveurl=https://web.archive.org/web/20131119160957/http://pds-europe.com/products |title=Products - The PDS Product Suite |publisher=Pathology Data Systems Ltd |archivedate=19 November 2013 |accessdate=10 September 2014}}</ref> as an integrated modular software suite called Ascentos.<ref name="PDSRebrand">{{cite web |url=http://www.pdslifesciences.com/march212014.aspx |title=PDS Set to Launch New Products and Branding at Society of Toxicology Annual Meeting |publisher=Pathology Data Systems Ltd |accessdate=10 September 2014}}</ref><ref name="ArchPDSHome">{{cite web |url=http://www.pdslifesciences.com/default.aspx |archiveurl=https://web.archive.org/web/20140910190827/http://www.pdslifesciences.com/default.aspx |title=PDS - Home |publisher=Pathology Data Systems Ltd |archivedate=10 September 2014 |accessdate=10 September 2014}}</ref> However, it's not clear if the modules function as stand-alone software like their predecessors or as dependent modules of the Ascentos platform. | ||
On September 1, 2021, [[Instem LSS Limited]] announced that it had acquired PDS. Noting that "PDS has been a direct competitor of Instem," and the desire "to concentrate our investment into a single line of products," in their press release<ref name="InstemPDS21">{{cite web |url=https://www.instem.com/news/articles/0109-instem-acquires-PDS-life-sciences.php |title=Instem Acquires PDS Life Sciences to Help Clients Bring Life Enhancing Products to Market Faster and More Efficiently |publisher=Instem LSS Limited |date=01 September 2021 |accessdate=28 November 2023}}</ref>, it is unsurprising that the Ascentos product of PDS is no longer showing on the website (as of 2023), and an "end-of-life policy" for Ascentos exists.<ref name="InstemEOLAsc">{{cite web |url=https://www.customercenter.instem.com/ascentos-end-of-life-policy/ |archiveurl=https://web.archive.org/web/20231128234609/https://www.customercenter.instem.com/ascentos-end-of-life-policy/ |title=Ascentos End-of-life Policy |publisher=Instem LSS Limited |archivedate=28 November 2023 |accessdate=28 November 2023}}</ref> | On September 1, 2021, [[Vendor:Instem LSS Limited|Instem LSS Limited]] announced that it had acquired PDS. Noting that "PDS has been a direct competitor of Instem," and the desire "to concentrate our investment into a single line of products," in their press release<ref name="InstemPDS21">{{cite web |url=https://www.instem.com/news/articles/0109-instem-acquires-PDS-life-sciences.php |title=Instem Acquires PDS Life Sciences to Help Clients Bring Life Enhancing Products to Market Faster and More Efficiently |publisher=Instem LSS Limited |date=01 September 2021 |accessdate=28 November 2023}}</ref>, it is unsurprising that the Ascentos product of PDS is no longer showing on the website (as of 2023), and an "end-of-life policy" for Ascentos exists.<ref name="InstemEOLAsc">{{cite web |url=https://www.customercenter.instem.com/ascentos-end-of-life-policy/ |archiveurl=https://web.archive.org/web/20231128234609/https://www.customercenter.instem.com/ascentos-end-of-life-policy/ |title=Ascentos End-of-life Policy |publisher=Instem LSS Limited |archivedate=28 November 2023 |accessdate=28 November 2023}}</ref> | ||
==Technology and products== | ==Technology and products== | ||
Latest revision as of 16:48, 29 March 2024
| Former type | Aktiengesellschaft |
|---|---|
| Industry | Laboratory informatics |
| Fate | Acquired |
| Defunct | 01 September 2021[1] |
| Headquarters | Dürrenhübelstrasse 9, Pratteln, Basel, Switzerland |
| Number of locations | 3 |
| Area served | Worldwide |
| Key people | Vicente Nogués |
| Products |
Products list
|
| Subsidiaries | PDS Pathology Data Systems Ltd. |
| Website | pdslifesciences.com |
| https://www.linkedin.com/company/pds-life-sciences/ |
PDS Group Holding AG—doing business as PDS Life Sciences or PDS— developed and distributed laboratory informatics software solutions for businesses working in preclinical science.
History
The company was formally founded in November 2007.[2]
On March 21, 2014, PDS announced it would be rebranding its PathData, ReproData, and ToxData products[3] as an integrated modular software suite called Ascentos.[4][5] However, it's not clear if the modules function as stand-alone software like their predecessors or as dependent modules of the Ascentos platform.
On September 1, 2021, Instem LSS Limited announced that it had acquired PDS. Noting that "PDS has been a direct competitor of Instem," and the desire "to concentrate our investment into a single line of products," in their press release[1], it is unsurprising that the Ascentos product of PDS is no longer showing on the website (as of 2023), and an "end-of-life policy" for Ascentos exists.[6]
Technology and products
Ascentos
Ascentos was a modular, cloud-based laboratory information management system (LIMS) for pre-clinical research and reporting for the life sciences and chemical industries.[7]
References
- ↑ 1.0 1.1 "Instem Acquires PDS Life Sciences to Help Clients Bring Life Enhancing Products to Market Faster and More Efficiently". Instem LSS Limited. 1 September 2021. https://www.instem.com/news/articles/0109-instem-acquires-PDS-life-sciences.php. Retrieved 28 November 2023.
- ↑ "PDS Group Holding AG". Commercial Register of canton Basel-Landschaft. https://bl.chregister.ch/cr-portal/suche/suche.xhtml. Retrieved 23 October 2019. "Search for PDS Group Holding AG or CHE-113.007.526"
- ↑ "Products - The PDS Product Suite". Pathology Data Systems Ltd. Archived from the original on 19 November 2013. https://web.archive.org/web/20131119160957/http://pds-europe.com/products. Retrieved 10 September 2014.
- ↑ "PDS Set to Launch New Products and Branding at Society of Toxicology Annual Meeting". Pathology Data Systems Ltd. http://www.pdslifesciences.com/march212014.aspx. Retrieved 10 September 2014.
- ↑ "PDS - Home". Pathology Data Systems Ltd. Archived from the original on 10 September 2014. https://web.archive.org/web/20140910190827/http://www.pdslifesciences.com/default.aspx. Retrieved 10 September 2014.
- ↑ "Ascentos End-of-life Policy". Instem LSS Limited. Archived from the original on 28 November 2023. https://web.archive.org/web/20231128234609/https://www.customercenter.instem.com/ascentos-end-of-life-policy/. Retrieved 28 November 2023.
- ↑ "Ascentos". PDS Group Holding AG. Archived from the original on 19 January 2021. https://web.archive.org/web/20210119084254/https://www.pdslifesciences.com/ascentos. Retrieved 28 November 2023.
